Current Assets

Derivative Assets - Fair Value

Pfizer Derivative Assets - Fair Value decreased by 31.7% to $41.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 91.6%, from $487.00M to $41.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

An increase indicates higher potential cash inflows and a stronger position in the derivative market.

Detailed definition

This represents the total fair value of derivative financial instruments that are in a net asset position at the reporti...

Peer comparison

Standard disclosure for all banks with significant trading or derivative portfolios.

Metric ID: derivative_assets_fair_value

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$35.00M$246.00M$532.00M$739.00M$1.50B$715.00M$422.00M$333.00M$251.00M$281.00M$104.00M$487.00M$42.00M$60.00M$41.00M
QoQ Change+602.9%+116.3%+38.9%+103.0%-52.3%-41.0%-21.1%-24.6%+12.0%-63.0%+368.3%-91.4%+42.9%-31.7%
YoY Change>999%+509.8%+34.4%-42.9%-77.8%-64.9%-33.4%-68.8%+94.0%-85.1%-42.3%-91.6%
Range$35.00M$1.50B
CAGR+4.6%
Avg YoY Growth+178.6%
Median YoY Growth-42.6%

Derivative Assets - Fair Value at Other Companies

Frequently Asked Questions

What is Pfizer's derivative assets - fair value?
Pfizer (PFE) reported derivative assets - fair value of $41.00M in Q1 2026.
How has Pfizer's derivative assets - fair value changed year-over-year?
Pfizer's derivative assets - fair value decreased by 91.6% year-over-year, from $487.00M to $41.00M.
What does derivative assets - fair value mean?
The current market value of all derivative contracts where the bank is in a net receivable position.